Search Results - "Puig, J Salas"

A new clinical score for the prognosis of status epilepticus in adults by González-Cuevas, M., Santamarina, E., Toledo, M., Quintana, M., Sala, J., Sueiras, M., Guzman, L., Salas-Puig, J.

“…Background and purpose The severity of status epilepticus (SE) has an important impact in clinical outcomes. The Status Epilepticus Severity Score (STESS) is a…”
Get full text

Outcome of cancer‐related seizures in patients treated with lacosamide by Toledo, M., Molins, A., Quintana, M., Santamarina, E., Martinez‐Ricarte, F., Martínez‐Saez, E., Salas‐Puig, J.

“…Objectives Lacosamide is an antiepileptic drug (AED), which has proven to be effective to control seizures, including acute conditions such as status…”
Get full text

Response to Dr Voring et al by González‐Cuevas, M., Santamarina, E., Toledo, M., Quintana, M., Sala, J., Sueiras, M., Guzman, L., Salas‐Puig, J.

Get full text

Low-dose sodium valproate in the treatment of idiopathic generalized epilepsies by Miró, J., Aiguabella, M., Veciana, M., Juvany, R., Santurino, M., Leiva, E., Salas-Puig, J., Falip, M.

“…Objective Most patients with idiopathic generalized epilepsies (IGEs) have good seizure control when on antiepileptic drugs. To analyze prospectively the…”
Get full text

Overnight switch from levetiracetam to brivaracetam. Safety and tolerability by Abraira, L., Salas-Puig, J., Quintana, M., Seijo-Raposo, I.M., Santamarina, E., Fonseca, E., Toledo, M.

“…•Brivaracetam has a more selective action to SV2A binding site than levetiracetam.•Neuropsychological adverse events improved in 76% of patients that…”
Get full text

Treatment initiation in epilepsy: An expert consensus in Spain by Villanueva, V, Sánchez-Álvarez, J.C, Peña, P, Puig, J. Salas, Caballero-Martínez, F, Gil-Nagel, A

“…Abstract Objective The goals of this study were to explore the diverse criteria surrounding indications for antiepileptic therapy and to establish a consensus…”
Get full text

Safety, efficacy and outcome-related factors of perampanel over 12 months in a real-world setting: The FYDATA study by Villanueva, V, Garcés, M, López-González, F.J, Rodriguez-Osorio, X, Toledo, M, Salas-Puig, J, González-Cuevas, M, Campos, D, Serratosa, J.M, Giráldez, B. González, Mauri, J.A, Camacho, J.L, Suller, A, Carreño, M, Gómez, J.B, Montoya, J, Uranga, J. Rodriguez, Saiz-Diaz, R, de la Aleja, J. González, Castillo, A, López-Trigo, J, Poza, J.J, Flores, J, Querol, R, Ojeda, J, Giner, P, Molins, A, Esteve, P, Baiges, J.J

“…Highlights • We report real-world data from 464 patients treated with perampanel over 1 year. • Efficacy and tolerability of perampanel were comparable with…”
Get full text

Long-term safety and efficacy of eslicarbazepine acetate in patients with focal seizures: Results of the 1-year ESLIBASE retrospective study by Villanueva, V, Serratosa, J.M, Guillamón, E, Garcés, M, Giráldez, B.G, Toledo, M, Salas-Puig, J, López González, F.J, Flores, J, Rodríguez-Uranga, J, Castillo, A, Mauri, J.A, Camacho, J.L, López-Gomáriz, E, Giner, P, Torres, N, Palau, J, Molins, A

“…Highlights • We evaluated eslicarbazepine acetate (ESL) in a clinical practice setting. • Three hundred and twenty-seven patients with poor seizure control or…”
Get full text

Prognosis of status epilepticus in elderly patients by Vilella, L., González Cuevas, M., Quintana Luque, M., Toledo, M., Sueiras Gil, M., Guzmán, L., Salas Puig, J., Santamarina Pérez, E.

“…Purpose To evaluate the clinical features and prognosis of status epilepticus (SE) in patients above 70 years old. Methods Retrospective analysis of all…”
Get full text

Angiotensin converting enzyme and endothelial nitric oxide synthase DNA polymorphisms and late onset Alzheimer's disease by Alvarez, Ruth, Alvarez, Victoria, Lahoz, Carlos H, Martínez, Carmen, Peña, Joaquín, Sánchez, José M, Guisasola, Luis M, Salas-Puig, Javier, Morís, Germán, Vidal, José A, Ribacoba, René, Menes, Bernardino B, Uría, Dionisio, Coto, Eliecer

“…OBJECTIVES Several lines of evidence suggest that the endothelial constitutive nitric oxide synthase (ecNOS) and angiotensin converting enzyme (ACE) may have a…”
Get full text

Lamotrigine and epilepsy in the elderly: observational study of low-dose monotherapy by Mauri Llerda, J A, Tejero, C, Mercadé, J M, Padró, L L, Salas Puig, J

“…A one-year prospective, observational study was conducted in 222 elderly patients (>65 years old) with epilepsy. Patients received 25 mg/day lamotrigine for…”
Get more information

Epilepsia mioclónica en el síndrome de Down y en la enfermedad de Alzheimer by Aller-Alvarez, J.S, Menéndez-González, M, Ribacoba-Montero, R, Salvado, M, Vega, V, Suárez-Moro, R, Sueiras, M, Toledo, M, Salas-Puig, J, Álvarez-Sabin, J

“…Resumen Introducción Los pacientes con síndrome de Down (SD) presentan una demencia tipo Alzheimer (EA) asociada a la edad. Ambas patologías, con una base…”
Get full text

Reflex seizures triggered by cutaneous stimuli by Sala-Padró, J, Toledo, M, Sarria, S, Santamarina, E, Gonzalez-Cuevas, M, Sueiras-Gil, M, Salas-Puig, J

“…Abstract Purpose Among the different precipitating stimuli for reflex seizures, Touch-Induced Seizures (TIS) and Hot Water Seizures (HWS) are consistently…”
Get full text

Myoclonic epilepsy in Down syndrome and Alzheimer disease by Aller-Alvarez, J S, Menéndez-González, M, Ribacoba-Montero, R, Salvado, M, Vega, V, Suárez-Moro, R, Sueiras, M, Toledo, M, Salas-Puig, J, Álvarez-Sabin, J

“…Patients with Down syndrome (DS) who exhibit Alzheimer disease (AD) are associated with age. Both diseases with a common neuropathological basis have been…”
Get more information

EFFICACY AND SAFETY OF ESLICARBAZEPINE-ACETATE IN ELDERLY PATIENTS WITH FOCAL EPILEPSY: CASE SERIES by Gómez-Ibáñez, A, Serratosa, J.M, Guillamón, E, Garcés, M, Giráldez, B.G, Toledo, M, Salas-Puig, J, López-González, F.J, Rodríguez-Uranga, J, Castillo, A, Mauri, J.A, Camacho, J.L, López-Gomáriz, E, Giner, P, Torres, N, Palau, J, Molins, A, Villanueva, V

“…Abstract Purpose Eslicarbazepine-acetate (ESL) is a third generation antiepileptic drug licensed as adjunctive therapy in adults with focal seizures. Efficacy…”
Get full text

Socio-occupational and employment profile of patients with epilepsy by Marinas, A, Elices, E, Gil-Nagel, A, Salas-Puig, J, Sánchez, J.C, Carreño, M, Villanueva, V, Rosendo, J, Porcel, J, Serratosa, J.M

“…Abstract Objective Epilepsy has a significant impact on quality of life. Many studies have observed higher unemployment rates among patients with epilepsy…”
Get full text

Corrigendum to ‘Reflex seizures triggered by cutaneous stimuli’ [Seizure 33 (2015) 72–75] by Sala-Padró, J, Toledo, M, Sarria, S, Santamarina, E, Gonzalez-Cuevas, M, Sueiras-Gil, M, Salas-Puig, J

Get full text

Epilepsia resistente a fármacos antiepilépticos: recomendaciones de actuación diagnóstica y terapéutica en España by Sánchez-Álvarez, J.C, Gil-Nagel, A, Casas-Fernández, C, Mauri-Llerda, J.A, Salas-Puig, J, Sancho-Rieger, J

“…Resumen Introducción La epilepsia resistente a fármacos antiepilépticos (ERF) constituye un problema socio-sanitario de primer nivel, que debe ser…”
Get full text

Erratum to “Safety, efficacy and outcome-related factors of perampanel over 12months in a real-world setting: The FYDATA study” [Epilepsy Res. 126 (2016) 201–210] by Villanueva, V, Garcés, M, López-González, F.J, Rodriguez-Osorio, X, Toledo, M, Salas-Puig, J, González-Cuevas, M, Campos, D, Serratosa, J.M, González-Giráldez, B, Mauri, J.A, Camacho, J.L, Suller, A, Carreño, M, Gómez, J.B, Montoya, J, Rodríguez-Uranga, J, Saiz-Diaz, R, González-de la Aleja, J, Castillo, A, López-Trigo, J, Poza, J.J, Flores, J, Querol, R, Ojeda, J, Giner, P, Molins, A, Esteve, P, Baigesr, J.J

Get full text

Strategies to detect adverse effects of antiepileptic drugs in clinical practice by Carreño, M, Gil-Nagel, A, Sánchez, J.C, Elices, E, Serratosa, J.M, Salas-Puig, J, Villanueva, V, Porcel, J

“…Abstract Objective The aim was to study the frequency and types of adverse effects (AEs) in patients treated with antiepileptic drugs (AEDs) according to the…”
Get full text